Full Press Release Details
CRISPR Therapeutics Announces $280 Million Registered Direct Offering.
CRSP
CRISPR Therapeutics Announces $280 Million Registered Direct Offering
Key Takeaway: CRISPR Therapeutics Announces $280 Million Registered Direct Offering
Price reaction · baseline $76.44 (2024-02-12 close) · hit after-hours · 1 other CRSP headline(s) in the window, move may be shared
day 0 close
-4.8%
day 1
+3.4%
day 3 · peak
+7.6%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+60%
120-day peak, hindsight
Typical move
2.4%
average across 2 past catalysts
Cash runway
~84 mo
Minimal dilution risk
Lead asset
CTX340
Phase 1 · Hypertension